Hosted on MSN1mon
Seattle’s newest unicorn: Truveta lands $320M to fuel creation of massive new genome projectThe new investment — which comes from 17 health systems, Illumina, and Regeneron — pushes Truveta’s valuation above $1 billion, making it the latest unicorn to emerge from the Seattle region.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback